Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Cleveland Clinic Foundation

Cleveland Clinic Foundation in Cleveland, Ohio, United States is listed as a site for 1,268 registered clinical trials, 388 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 1,268
Ongoing 388

This page covers the site record Cleveland Clinic Foundation in Cleveland, Ohio, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Cleveland Clinic Foundation report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 1,268 trials counted.

  • Phase 1 69 trials
  • Phase 1/2 36 trials
  • Phase 2 305 trials
  • Phase 2/3 51 trials
  • Phase 3 372 trials
  • Phase 4 29 trials
  • Not applicable 241 trials
  • Observational 157 trials
  • Expanded access 7 trials
  • Unknown 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 389 trials
  • Completed 702 trials
  • Terminated 137 trials
  • Other 40 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational
  • Other (Expanded access, Unknown)

Top of scale: 73

1992: 1 trials (Phase 2/3 1) 1994: 1 trials (Phase 3 1) 1996: 1 trials (Phase 3 1) 1997: 1 trials (Other 1) 1998: 4 trials (Observational 1, Phase 3 3) 1999: 2 trials (Observational 1, Phase 3 1) 2000: 8 trials (Observational 1, Phase 3 5, Phase 2/3 1, Phase 2 1) 2001: 11 trials (Phase 4 1, Phase 3 5, Phase 2/3 3, Phase 2 1, Phase 1 1) 2002: 23 trials (Observational 1, Not applicable 2, Phase 4 2, Phase 3 7, Phase 2/3 2, Phase 2 7, Phase 1/2 2) 2003: 25 trials (Observational 3, Phase 4 1, Phase 3 8, Phase 2/3 3, Phase 2 10) 2004: 32 trials (Observational 4, Not applicable 2, Phase 3 17, Phase 2/3 1, Phase 2 5, Phase 1/2 1, Phase 1 2) 2005: 47 trials (Observational 3, Not applicable 4, Phase 3 18, Phase 2/3 2, Phase 2 11, Phase 1/2 6, Phase 1 3) 2006: 73 trials (Observational 18, Not applicable 6, Phase 4 4, Phase 3 28, Phase 2 14, Phase 1 3) 2007: 54 trials (Observational 11, Not applicable 6, Phase 4 3, Phase 3 21, Phase 2/3 1, Phase 2 8, Phase 1/2 2, Phase 1 2) 2008: 36 trials (Observational 9, Not applicable 3, Phase 4 3, Phase 3 10, Phase 2/3 1, Phase 2 9, Phase 1 1) 2009: 56 trials (Observational 11, Not applicable 5, Phase 4 2, Phase 3 23, Phase 2 13, Phase 1/2 1, Phase 1 1) 2010: 55 trials (Observational 4, Not applicable 11, Phase 3 14, Phase 2 22, Phase 1/2 1, Phase 1 3) 2011: 55 trials (Observational 8, Not applicable 14, Phase 4 1, Phase 3 15, Phase 2/3 1, Phase 2 12, Phase 1 4) 2012: 52 trials (Observational 4, Not applicable 11, Phase 4 1, Phase 3 14, Phase 2 19, Phase 1/2 1, Phase 1 2) 2013: 51 trials (Other 1, Observational 6, Not applicable 15, Phase 3 9, Phase 2/3 1, Phase 2 12, Phase 1/2 3, Phase 1 4) 2014: 69 trials (Observational 7, Not applicable 14, Phase 3 14, Phase 2/3 9, Phase 2 18, Phase 1/2 1, Phase 1 6) 2015: 47 trials (Observational 7, Not applicable 6, Phase 4 1, Phase 3 13, Phase 2/3 1, Phase 2 14, Phase 1/2 1, Phase 1 4) 2016: 49 trials (Observational 7, Not applicable 13, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 10, Phase 1/2 4, Phase 1 3) 2017: 68 trials (Observational 9, Not applicable 16, Phase 4 1, Phase 3 14, Phase 2/3 1, Phase 2 23, Phase 1/2 2, Phase 1 2) 2018: 44 trials (Observational 7, Not applicable 8, Phase 3 9, Phase 2/3 5, Phase 2 13, Phase 1 2) 2019: 69 trials (Observational 7, Not applicable 13, Phase 3 26, Phase 2/3 5, Phase 2 13, Phase 1/2 1, Phase 1 4) 2020: 54 trials (Observational 4, Not applicable 12, Phase 4 2, Phase 3 14, Phase 2/3 2, Phase 2 17, Phase 1 3) 2021: 58 trials (Observational 7, Not applicable 12, Phase 4 1, Phase 3 16, Phase 2/3 3, Phase 2 14, Phase 1/2 2, Phase 1 3) 2022: 52 trials (Observational 5, Not applicable 11, Phase 4 1, Phase 3 11, Phase 2/3 3, Phase 2 13, Phase 1/2 2, Phase 1 6) 2023: 48 trials (Observational 2, Not applicable 16, Phase 4 2, Phase 3 12, Phase 2/3 4, Phase 2 9, Phase 1/2 1, Phase 1 2) 2024: 38 trials (Observational 7, Not applicable 13, Phase 3 10, Phase 2 5, Phase 1 3) 2025: 46 trials (Observational 1, Not applicable 18, Phase 3 16, Phase 2 6, Phase 1/2 2, Phase 1 3)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 23
2025 46
2024 38
2023 48
2022 52
2021 58
2020 54
2019 69
2018 44
2017 68

Showing 10 of 33 years.

Start your 14-day trial Email me all 33 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 1,268 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 259 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 621 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF